Medications starting with
Poland-
It is used to increase circulating blood volume. It helps, among other things, in the treatment of shock (e.g., after burns, hemorrhages, or surgery), improves blood properties, prevents venous thrombosis and pulmonary embolism, and protects microcirculation.
Dosage form: solution for infusion
Active substance Dosage dextran 100 g ATC code: B05AA05
Manufacturer: Fresenius Kabi Italia S.r.L.
-
The vaccine protects against diphtheria caused by Corynebacterium diphtheriae. It helps the body produce antibodies that prevent the disease.
Dosage form: suspension for injection
Active substance Dosage diphtheria toxoid not less than 5 IU ATC code: J07AF01
Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.
-
The vaccine is used to immunize children against diphtheria.
Dosage form: suspension for injection
Active substance Dosage diphtheria toxoid not less than 30 IU ATC code: J07AF01
Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 86.48 mg ATC code: B01AE07
Manufacturer: Pharmadox Healthcare Ltd., TOWA Pharmaceuticals Europe, S.L.
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg veins and lungs. In children, the medicine is used to treat blood clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 126.83 mg ATC code: B01AE07
Manufacturer: Pharmadox Healthcare Ltd., TOWA Pharmaceuticals Europe, S.L.
-
This medicine is used in adults to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of blood clots in the veins of the legs and lungs. In children, it is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 172.95 mg ATC code: B01AE07
Manufacturer: Pharmadox Healthcare Ltd., TOWA Pharmaceuticals Europe, S.L.
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children aged 8 years and older, it is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 75 mg ATC code: B01AE07
Manufacturer: Adamed Pharma S.A.
-
In adults, it is used to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children over 8 years of age, it is used for the treatment and prevention of recurrence of blood clots.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 150 mg ATC code: B01AE07
Manufacturer: Adamed Pharma S.A.
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children over 8 years of age, it is used to treat blood clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 110 mg ATC code: B01AE07
Manufacturer: Adamed Pharma S.A.
-
This medicine is used in adults to prevent blood clots in the brain (stroke) and other blood vessels in atrial fibrillation, and to treat and prevent the recurrence of blood clots in the veins of the legs and lungs. In children, it is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 150 mg ATC code: B01AE07
Manufacturer: Laboratorios Liconsa S.A.
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 110 mg ATC code: B01AE07
Manufacturer: Laboratorios Liconsa S.A.
-
In adults, it is used to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 75 mg ATC code: B01AE07
Manufacturer: Laboratorios Liconsa S.A.
-
The medicine is used in adults to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of blood clots in the leg veins and lungs. In children, it is used to treat and prevent the recurrence of blood clots.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 150 mg ATC code: B01AE07
Manufacturer: Laboratorios Liconsa S.A.
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 110 mg ATC code: B01AE07
Manufacturer: Laboratorios Liconsa S.A.
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 75 mg ATC code: B01AE07
Manufacturer: Laboratorios Liconsa S.A.
-
This medicine is used in adults to prevent blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation with an additional risk factor), as well as to treat and prevent the recurrence of clots in the veins of the legs and lungs. In children, the medicine is used to treat clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 150 mg ATC code: B01AE07
Manufacturer: Laboratorios Liconsa S.A.
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 75 mg ATC code: B01AE07
Manufacturer: Laboratorios Liconsa S.A.
-
The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, to prevent strokes and clots in other vessels in people with atrial fibrillation, and to treat and prevent the recurrence of clots in the leg and lung veins. In children, it is used to treat clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 110 mg ATC code: B01AE07
Manufacturer: Laboratorios Liconsa S.A.
-
The medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children, it is used for the treatment and prevention of recurrence of blood clots.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 172.95 mg ATC code: B01AE07
Manufacturer: Galenicum Health S.L. SAG Manufacturing S.L.U.
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 126.83 mg ATC code: B01AE07
Manufacturer: Galenicum Health S.L. SAG Manufacturing S.L.U.
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 86.48 mg ATC code: B01AE07
Manufacturer: Galenicum Health S.L. SAG Manufacturing S.L.U.
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 75 mg ATC code: B01AE07
Manufacturer: Orion Corporation Orion Pharma
-
In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 150 mg ATC code: B01AE07
Manufacturer: Orion Corporation Orion Pharma
-
This medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 110 mg ATC code: B01AE07
Manufacturer: Orion Corporation Orion Pharma
-
In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 150 mg ATC code: B01AE07
Manufacturer: Galenicum Health, S.L.U. SAG MANUFACTURING, S.L.U.
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 110 mg ATC code: B01AE07
Manufacturer: Galenicum Health, S.L.U. SAG MANUFACTURING, S.L.U.
-
In adults, it is used to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 75 mg ATC code: B01AE07
Manufacturer: Galenicum Health, S.L.U. SAG MANUFACTURING, S.L.U.
-
In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children, the medicine is used for the treatment and prevention of recurrence of blood clots.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 172.95 mg ATC code: B01AE07
Manufacturer: Laboratori Fundacio Dau Pharmadox Healthcare Limited
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 126.83 mg ATC code: B01AE07
Manufacturer: Laboratori Fundacio Dau Pharmadox Healthcare Limited
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 86.48 mg ATC code: B01AE07
Manufacturer: Laboratori Fundacio Dau Pharmadox Healthcare Limited
-
In adults, this medicine is used to prevent the formation of blood clots in the veins after hip or knee replacement surgery. In children, it is used to treat blood clots and to prevent them from recurring.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 75 mg ATC code: B01AE07
Manufacturer: Betapharm Arzneimittel GmbH
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 110 mg ATC code: B01AE07
Manufacturer: Betapharm Arzneimittel GmbH
-
This medicine is used in adults to prevent strokes and blood clots (in atrial fibrillation) and in the treatment and prevention of blood clots in the veins of the legs and lungs. In children, the medicine is used to treat and prevent recurrences of blood clots.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 150 mg ATC code: B01AE07
Manufacturer: Betapharm Arzneimittel GmbH
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 86.48 mg ATC code: B01AE07
Manufacturer: Galenicum Health S.L. Pharmadox Healthcare Limited SAG Manufacturing S.L.U. STADA Arzneimittel AG
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes and blood clots in other vessels in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the veins of the legs and lungs. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 126.83 mg ATC code: B01AE07
Manufacturer: Galenicum Health S.L. Pharmadox Healthcare Limited SAG Manufacturing S.L.U. STADA Arzneimittel AG
-
The medicine is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels (in atrial fibrillation) and to treat and prevent the recurrence of clots in the veins of the legs and lungs. In children, the medicine is used to treat clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 1472.95 mg ATC code: B01AE07
Manufacturer: Galenicum Health S.L. Pharmadox Healthcare Limited SAG Manufacturing S.L.U. Stada AG
-
In adults, it is used to prevent the formation of blood clots in the veins following knee or hip replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 75 mg ATC code: B01AE07
Manufacturer: Mylan Germany GmbH, Mylan Hungary Ltd.
-
In adults, it is used to prevent strokes and blood clots (in cases of irregular heart rhythm) and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 150 mg ATC code: B01AE07
Manufacturer: Mylan Germany GmbH, Mylan Hungary Ltd.
-
The medicine is used in adults to prevent blood clots after knee or hip replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, it is used to treat blood clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 110 mg ATC code: B01AE07
Manufacturer: Mylan Germany GmbH, Mylan Hungary Ltd.
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg and lung veins. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 126.8384 mg ATC code: B01AE07
Manufacturer: Pharmathen International S.A.
-
The medicine is used in adults to prevent the formation of blood clots in the brain and other blood vessels (in atrial fibrillation) and for the treatment and prevention of recurrence of blood clots in the veins of the legs and lungs. In children, the medicine is used for the treatment and prevention of recurrence of blood clots.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 172.9615 mg ATC code: B01AE07
Manufacturer: Pharmathen International S.A.
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, it is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 86.4808 mg ATC code: B01AE07
Manufacturer: Pharmathen International S.A.
-
The medicine is used in the treatment of Parkinson's disease. It helps to shorten the duration of periods of immobility (so-called "off" states) in people who have previously been treated with levodopa or other dopamine agonists.
Dosage form: solution for injection in the insert
Active substance Dosage apomorphine hydrochloride hemihydrate 10 mg/ml ATC code: N04BC07
Manufacturer: Ever Neuro Pharma GmbH, EVER Pharma Jena GmbH, EVER Pharma Jena GmbH
-
The medicine is used in the treatment of Parkinson's disease. It helps to reduce the duration of "off" periods, i.e., periods of immobility in patients who were previously treated with levodopa or other dopamine agonists.
Dosage form: solution for infusion
Active substance Dosage apomorphine hydrochloride hemihydrate 5 mg/ml ATC code: N04BC07
Manufacturer: EVER Pharma Jena GmbH
-
The medicine is used to treat type 2 diabetes in adults and children over 10 years of age, in adults for heart failure, and in adults with chronic kidney disease.
Dosage form: tablets, film-coated
Active substance Dosage dapagliflozin 5 mg ATC code: A10BK01
Manufacturer: Mylan Germany GmbH, Mylan Hungary Ltd.
-
The medicine is used to treat type 2 diabetes in adults and children over 10 years of age, heart failure in adults, and chronic kidney disease in adults.
Dosage form: tablets, film-coated
Active substance Dosage dapagliflozin 10 mg ATC code: A10BK01
Manufacturer: Mylan Germany GmbH, Mylan Hungary Ltd.
-
It is an antibacterial medicine used to treat acute and chronic, uncomplicated lower urinary tract infections caused by Escherichia coli bacteria. It is intended for children and adults.
Dosage form: suspension, oral
Active substance Dosage furazolidone 10 mg/ml ATC code: J01XE03
Manufacturer: Aflofarm Farmacja Polska Limited
-
The medicine is used in the case of lower urinary tract infection.
Dosage form: tablets
Active substance Dosage furazidinum 100 mg ATC code: J01XE03
Manufacturer: Aflofarm Farmacja Polska Limited
-
Dagetia is used to treat type 2 diabetes in adults and children over 10 years of age, in adults for heart failure, and in adults with chronic kidney disease.
Dosage form: tablets, film-coated
Active substance Dosage dapagliflozin 10 mg ATC code: A10BK01
Manufacturer: PharmaPath S.A.
-
The medicine is used to treat type 2 diabetes in adults and children over 10 years of age, in adults for heart failure, and in adults with chronic kidney disease.
Dosage form: tablets, film-coated
Active substance Dosage dapagliflozin 5 mg ATC code: A10BK01
Manufacturer: PharmaPath S.A.